Housing financier Altum Credo has secured INR 170 Cr ($19.4 Mn) in equity from existing investor British International Investment (BII), the development finance arm of the UK government.
It plans to utilise the freshly raised funds to scale up its operations across its current markets in India.
The company said that the proceeds will help expand credit access for low-income customers, primarily women, to support home construction and renovation.
“This investment further strengthens our balance sheet for a long-term sustainable impactful growth journey and our commitment to cater meaningfully to the large unmet demand for affordable housing finance in India,” said Vikrant Bhagwat, managing director and chief executive of Altum Credo.
Founded in 2017 by Bhagwat, Ganesh Rao and Ashish Tewari, Altum Credo provides technology-driven affordable housing finance solutions across India. It is primarily focused to cater to the overlooked potential of unserved and underserved segments and targets first-time homeowners.
The company previously raised around $40 Mn in its Series C funding round, in April 2024, to scale its distribution network.
Excluding the new funding, Altum Credo has raised around $62 Mn since its inception from investors such as Z3Partners, Oikocredit, Aavishkaar Capital and Amicus Capital, among others.
The housing financier claims to have served more than 15,000 customers in six states, with assets under management (AUM) exceeding INR 1,000 Cr.
(The story will be updated soon)
The post Altum Credo Nets INR 170 Cr To Expand Tech-Driven Housing Finance Solutions appeared first on Inc42 Media.
You may also like
Adani Green Energy's rating upgraded to AA with 'Stable' outlook over robust growth
I walked Europe's most famous city for 8 days - there's 1 thing every visitor needs to do
Inside the luxury sleeper train ride through beautiful country with temples and elephants
'I refused to give up my bus seat for elderly passenger – I deserve a seat too'
IMA Pune Welcomes GST Cut On Cancer & Essential Medicines; Urges Full GST Exemption On Anti-Cancer, Diabetic, Cardiac Drugs